Administration of WY14643 significantly ameliorated colitis symptoms and reduced the expression levels of inflammatory genes, such as interferon-γ, tumor necrosis factor-α, interleukin-1β, and interleukin-6 in colon tissues. Here, TNF is linked to colitis.